Xanthine oxidoreductase in respiratory and cardiovascular disorders

A Boueiz, M Damarla… - American Journal of …, 2008 - journals.physiology.org
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell
… Regulation of endothelial cell xanthine dehydrogenase xanthine oxidase gene expression

Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts

AV Naumova, VP Chacko… - … Physiology-Heart …, 2006 - journals.physiology.org
… are similar to those of heart failure and offer an additional potential … Xanthine oxidase (XO)
is important in purine metabolism, and its expression and activity are increased in heart failure

Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?

RJ Hajjar, JA Leopold - Circulation research, 2006 - Am Heart Assoc
… In the failing heart, there is experimental evidence to suggest that xanthine oxidoreductase
(XOR), comprised of the isoenzymes XO and xanthine dehydrogenase (XDH), is an important …

Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure

LC Amado, AP Saliaris, SVY Raju, S Lehrke… - Journal of molecular and …, 2005 - Elsevier
… We hypothesized that chronic xanthine oxidase inhibition (XOI) would have favorable
effects on both ventricular and vascular performance in evolving heart failure (HF), thereby …

The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study

HE Cingolani, JA Plastino, EM Escudero… - … of cardiac failure, 2006 - Elsevier
… of congestive heart failure (CHF). We examined whether inhibition of the superoxide anion
(·O 2 − )-generating enzyme xanthine oxidase (XO) with oxypurinol may improve cardiac

Uric acid and xanthine oxidase in heart failure—Emerging data and therapeutic implications

W Doehner, EA Jankowska, J Springer… - International journal of …, 2016 - Elsevier
… the increased activity of the enzyme xanthine oxidase (XO) with corresponding increased
the recent evidence on XO as a novel and promising therapeutic target in heart failure. …

Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat

E Yamamoto, K Kataoka, T Yamashita, Y Tokutomi… - …, 2007 - Am Heart Assoc
… diastolic heart failure in DS rats by causing reverse cardiac remodeling. Cardiac xanthine
oxidoreductase … Although the detailed mechanism of systolic heart failure has been extensively …

[HTML][HTML] Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme

MG Battelli, A Bolognesi, L Polito - … Acta (BBA)-Molecular Basis of Disease, 2014 - Elsevier
… For instance, patients with chronic heart failure due to dilated cardiomyopathy showed an
up-regulated expression of XOR, and the inhibition of enzyme activity by allopurinol …

[HTML][HTML] Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance

K Tziomalos, JM Hare - Frontiers in bioscience (Landmark edition), 2009 - ncbi.nlm.nih.gov
… in heart failure. The principal sources of reactive oxygen species in the cardiomyocyte
are xanthine oxidoreductase (XOR), nicotinamide adenine dinucleotide phosphate oxidase (…

Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study

MM Givertz, KJ Anstrom, MM Redfield, A Deswal… - Circulation, 2015 - Am Heart Assoc
… In high-risk HF patients with reduced ejection fraction and elevated uric acid levels, xanthine
oxidase inhibition with allopurinol failed to improve clinical status, exercise capacity, quality …